期刊文献+

胸腺瘤的诊断和预后影响因素分析 被引量:3

Influence factors on diagnosis and prognosis of thymoma: analysis of 135 cases
原文传递
导出
摘要 目的 探讨影响胸腺瘤的诊断与预后的相关因素。方法 回顾性分析 135例胸腺瘤患者的临床资料 ,logistic回归分析影响肿瘤复发的相关因素。 结果 胸腺瘤的临床表现多样 ,最常见的是重症肌无力 (6 6 / 135 ,4 8 9% )。出现上腔静脉压迫症状提示肿瘤为恶性 (χ2 =8 373,P =0 0 0 4 )。病程长、男性患者患恶性胸腺瘤的可能性较大 (U =16 91 5 ,P =0 0 13;χ2 =6 12 5 ,P =0 0 13)。胸腺瘤是否钙化及坏死与肿瘤的良恶性无关 (χ2 =0 12 1,P =0 72 8;χ2 =0 4 87,P =0 4 85 )。肿瘤的复发与患者的病程和Masaoka分期呈正相关 [Exp(b) =1 0 5 0、6 72 8,P =0 0 38、0 0 0 3],年龄小、女性患者复发机会小。胸腺瘤复发率Ⅰ期为 2 7% ,Ⅱ期为 11 1% ,Ⅲ期为 30 4 % ,Ⅳ期为 83 3%。结论 胸腺瘤是一种起病隐匿、表现多样的疾病 ,其影像学表现对良恶性的判断欠准确 ,Masaoka分期能提示患者的预后 ; Objective To investigate the clinical features and prognostic factors of thymoma. Methods 135 patients with a diagnosis of thymoma or thymic carcinoma were identified in Peking Union Medical University Hospital from Jan,1990 to Feb,2003. Their clinical presentation and prognostic factors were analyzed. Results Of the 135 patients, 21 (15.6%) were asymptomatic and 66 (48.9%) presented symptoms consistent with myasthenia gravis. Venous obstruction, male gender and longer disease course appeared to be the predisposing factors of malignancy (χ~2=8.373, P=0.004; χ~2=6.125, P=0.013; (U=)1691.5, P=0.013 respectively). Calcification and necrosis on radiological findings did not differentiate thymoma from thymic carcinoma. Tumor recurrence was related to the Masaoka stage and the course of disease by logistic method [Exp(b)= 1.050?6.728,P=0.038?0.003]. The recurrence rate was 2.7% in stageⅠ, 11.1% in stage Ⅱ, 30.4% in stage Ⅲ, and 83.3% in stage Ⅳ. Conclusions Thymoma has a variable clinical manifestation. Clinical outcome is correlated with Masaoka stage and early tumor resection. Radiographic findings are not reliable in the differentiation of benign tumor from malignancy.
出处 《中华内科杂志》 CAS CSCD 北大核心 2004年第9期657-660,共4页 Chinese Journal of Internal Medicine
关键词 胸腺瘤 诊断 肿瘤 患者 预后 恶性 病程 疾病 影响因素分析 年龄 Thymoma Radiological findings Diagnosis Prognosis
  • 相关文献

参考文献11

  • 1Masaoka A,Monden Y,Nakahara K,et al.Follow-up study of thymomas with special reference to their clinical stages.Cancer,1981,48:2485-2492.
  • 2Ramon y Cajal S,Suster S.Primary thymic epithelial neoplasms in children.Am J Surg Pathol,1991,15:466-474.
  • 3Graeber GM,Tamim W.Current status of the diagnosis and treatment of thymoma.Semin Thorac Cardiovasc Surg,2000,12:268-277.
  • 4Lewis JE,Wick MR,Scheithauer BW,et al.Thymoma.A clinicopathologic review.Cancer,1987,60:2727-2743.
  • 5Regnard JF,Magdeleinat P,Dromer C,et al.Prognostic factors and long-term results after thymoma resection:a series of 307 patients.J Thorac Cardiovasc Surg,1996,112:376-384.
  • 6Cowen D,Richaud P,Mornex F,et al.Thymoma:results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature.FNCLCC trialists.Federation Nationale des Centres de Lutte Contre le Cancer.Radiother Oncol,1995
  • 7Graeber GM,Tamin W.Current status of the diagnosis and treatment of thymoma.Semin Thorac Cardiovasc Surg,2000,12:268-277.
  • 8Gripp S,Hilgers K,Wurm R,et al.Thymoma:prognostic factors and treatment outcomes.Cancer,1998,83:1495-1503.
  • 9Kondo K,Monden Y.Therapy for thymic epithelial tumors:a clinical study of 1,320 patients from Japan.Ann Thorac Surg,2003,76:878-885.
  • 10王云喜,孙玉鹗,张军,刘颖,徐燕杰.胸腺瘤的诊断、治疗和预后[J].中华外科杂志,2002,40(4):294-297. 被引量:10

二级参考文献3

共引文献17

同被引文献19

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部